Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3209 participants.

Also called NCT03310125

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 3,209 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03310125
Main results
  • Effect of colchicine on perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery (COP-AF): an international randomised trial Lancet (London, England), 2023-11-04 DOI, PubMed 37640035

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Austria, Belgium, Canada, Colombia, Hong Kong SAR China, Italy, Malaysia, Pakistan, Spain, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03310125. Randomized; quadruple masking; primary purpose prevention. Start 2018-02-14 (actual); primary completion 2023-06-01 (actual). Results posted on 2026-10-16.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF)
Acronym
COP-AF
Condition
Myocardial Injury After Non-Cardiac Surgery
Intervention (Drug)
Active Colchicine
Intervention (Drug)
Active Placebo
Lead sponsor
Population Health Research Institute (class: other)
Collaborator
Hamilton Health Sciences Corporation (class: other)

Record details

Record id
cardio:ct-nct03310125
Content hash
afdf2fde17430e1b81512b9ededa4183f1c480b3bebeaa42ad4de155c4b2c367